Baron Wealth Management
WST icon

Baron Wealth Management’s West Pharmaceutical WST Stock Holding History

Baron Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$433K Sell
1,169
-5
-0.4% -$1.76K 0.11% 139
2026
Q2 		$421K Buy
1,174
+20
+2% +$6.12K 0.11% 134
2026
Q1 		$289K Sell
1,154
-20
-2% -$4.98K 0.09% 190
2025
Q4 		$323K Sell
1,174
-2
-0.2% -$547 0.1% 163
2025
Q3 		$308K Sell
1,176
-422
-26% -$103K 0.1% 153
2025
Q2 		$350K Sell
1,598
-259
-14% -$55.4K 0.12% 126
2025
Q1 		$416K Sell
1,857
-69
-4% -$19K 0.18% 89
2024
Q4 		$631K Buy
1,926
+35
+2% +$11K 0.3% 52
2024
Q3 		$568K Buy
1,891
+132
+8% +$40.4K 0.27% 55
2024
Q2 		$579K Sell
1,759
-11
-0.6% -$3.89K 0.3% 49
2024
Q1 		$700K Hold
1,770
– – 0.37% 38
2023
Q4 		$623K Hold
1,770
– – 0.34% 44
2023
Q3 		$664K Buy
1,770
+24
+1% +$9.28K 0.42% 30
2023
Q2 		$668K Buy
1,746
+7
+0.4% +$2.5K 0.42% 30
2023
Q1 		$603K Hold
1,739
– – 0.43% 32
2022
Q4 		$409K Buy
+1,739
New +$412K 0.31% 57

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Baron Wealth Management's WST Position: Q3 2026 in Review

Baron Wealth Management reduced its West Pharmaceutical (WST) stake by 0.43% in Q3 2026, selling an estimated $1.76K and leaving 1,169 shares worth $433K. The position accounts for 0.11% of the portfolio, ranked #139.

Baron Wealth Management first reported a position in WST in Q4 2022 and has held it in 16 quarters since. The position peaked at $700K in Q1 2024. 430 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Baron Wealth Management held 1,169 shares of West Pharmaceutical worth $433K as of Q3 2026.
  • Baron Wealth Management sold 5 West Pharmaceutical shares in Q3 2026, an estimated $1.76K.
  • West Pharmaceutical made up 0.11% of Baron Wealth Management's portfolio in Q3 2026, its #139 holding.
  • Baron Wealth Management first reported a position in West Pharmaceutical in Q4 2022 and has held it in 16 quarters since.
  • Baron Wealth Management's West Pharmaceutical position peaked at $700K in Q1 2024.
  • 430 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Baron Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.